Toggle light / dark theme

Magic mushrooms’ show promise for improving motor function and mood in Parkinson’s patients

Psilocybin, a natural compound found in certain mushrooms, has shown promise in treating depression and anxiety. UC San Francisco researchers wanted to know if it could be used to help Parkinson’s patients who often experience debilitating mood dysfunction in addition to their motor symptoms and don’t respond well to antidepressants or other medications.

The results were surprising.

Not only did participants tolerate the drug without or worsening symptoms, which is what the was designed to test, they also experienced clinically significant improvements in mood, cognition, and that lasted for weeks after the drug was out of their systems.

A Scientist Grew a Groundbreaking New ‘Mutant’ Form of Magic Mushroom

When you think of a mushroom—whether psilocybin or portobello—you probably envision a stem and cap common for this type of fungi. The new Snowball mushroom is anything but typical.

This particular strain of “magic mushroom” is aptly named, as it resembles dozens of snowballs packed together. Mycologist Pope Joseph painstakingly coaxed a mutation from another mushroom species into creating the look he wanted, says Drew Collins, founder and CEO of InoculateTheWorld (ITW). His company distributes mushroom spores and introduced the Snowball mushroom to the world.

The Snowball is a significant development in growing mushrooms that have psilocybin, a compound that causes psychedelic effects, such as visual and auditory hallucinations. This form is unlike anything that’s ever been seen in mushroom cultivation before, Collins says. “I’ve been describing it as that moment you look out the window of a plane and there’s a never ending field of clouds.”

Case report: Magic mushrooms may induce lasting improvements in color-blind vision

Researchers at the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute at the Cleveland Clinic in Ohio have authored a case report on the positive effects of psilocybin on color blindness.

Published in the journal Drug Science, Policy and Law, the researchers highlight some implications surrounding a single reported vision improvement self-study by a colleague and cite other previous reports, illustrating a need to understand better how these psychedelics could be used in therapeutic settings.

Past reports have indicated that people with deficiency (CVD), usually referred to as , experience better color vision after using lysergic acid diethylamide (LSD) or psilocybin (magic mushrooms). There is a lack of scientific evidence for these claims, as researching the effects of these drugs has been highly restricted.